The intellectual property model that has been and is probably still being used in the pharmaceutical sector is rather restrictive and rigid. There was a lot of distress, especially in the Montreal area, when pharmaceutical research centres were shut down.
How do you see the future? We are talking about a more restrictive intellectual property model and stricter protection rules. What type of intellectual property system do you see for the future, be it in the pharmaceutical sector or other sectors?